Related articles from FindarticlesChain Drug Review - Adderall in Canada
September 26, 2005 -- Shire Pharmaceuticals Group PLC's Adderall XR has returned to the Canadian market. The product, for attention-deficit/ hyperactivity disorder, had...M2 Presswire - Statement on Adderall.
February 11, 2005 -- M2 PRESSWIRE-11 February 2005-US FDA: Statement on Adderall(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:02092005 FDA is aware of Health Canada's...Chain Drug Review - Adderall approval
August 30, 2004 -- The FDA has cleared Adderall XR to treat attention Deficit hyperactivity disorder in Adults. The Shire Pharmaceuticals Group PLC product is said to...Independent, The (London) - Shire buoyed by Adderall sales
July 29, 2005 -- Shire Pharmaceuticals, the FTSE 100 drug company which clinched a pounds 900m acquisition in the US this week, told the City to expect higher-...Pediatrics for Parents - Adderall XR approved in Canada
March 1, 2005 -- Adderall XR is a long-acting version of Adderall, a drug used to treat attention deficit hyperactivity disorder (ADHD). Earlier this year, the drug...Internal Medicine News - Health Canada reinstates Adderall XR
November 1, 2005 -- Patients in Canada with attention-deficit hyperactivity disorder are now able to obtain Adderall XR. Sales of the controlled-release amphetamine...Independent, The (London) - Shire plans Adderall replacement
November 5, 2004 -- SHIRE PHARMACEUTICALS, the FTSE 100 drug maker, plans to launch six new drugs before the end of 2006. They include new treatments for attention...Clinical Psychiatry News - Health Canada reinstates Adderall XR
October 1, 2005 -- Patients in Canada with attention-deficit hyperactivity disorder are now able to obtain Adderall XR. Sales of the controlled-release amphetamine...Pediatric News - Aczone Gel, 5% and Adderall XR
September 1, 2005 -- Aczone Gel, 5% (Dapsone gel, QLT Inc.) The Food and Drug Administration approved Aczone (dapsone) Gel, 5% for the topical treatment of acne...Chain Drug Review - Health Canada stops sales of Adderall
February 28, 2005 -- WASHINGTON -- The Food and Drug Administration says it is engaged in close consultation with Health Canada concerning the latter's decision to... |
| |
